MedTrace Logo

Asthma Patient Survey Study to Assess Asthma Effect and Medication in Finland

NCT00681382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2011-01-24

No results posted yet for this study

Summary

This study was aimed at clarifying how the asthma medication is used in practice and how asthma affects everyday life. Total of 106 GPs were asked to recruit patients using inhaled steroid as maintenance treatment for asthma to take part in a telephone survey. Altogether 142 patients were interviewed.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Airi Puhakka · AstraZeneca Finland

  • Jouni Hedman · South Karelia Central Hospital, Finland

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2007-04-30
Completion
2007-04-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00681382 on ClinicalTrials.gov